Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,889
archived clinical trials in
Blood Cancer

357
mi
from 43215
Greenville, SC
Greenville Hospital Cancer Center
357
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
354
mi
from 43215
Greenville, SC
CCOP - Greenville
354
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
351
mi
from 43215
Greer, SC
Cancer Centers of the Carolinas - Greer Medical Oncology
351
mi
from 43215
Greer, SC
Click here to add this to my saved trials
364
mi
from 43215
Seneca, SC
Cancer Centers of the Carolinas - Seneca
364
mi
from 43215
Seneca, SC
Click here to add this to my saved trials
349
mi
from 43215
Spartanburg, SC
Cancer Centers of the Carolinas - Spartanburg
349
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
303
mi
from 43215
Danville, VA
Danville Regional Medical Center
303
mi
from 43215
Danville, VA
Click here to add this to my saved trials
284
mi
from 43215
Martinsville, VA
Ravenel Oncology Center at Memorial Hospital of Martinsville and Henry County
284
mi
from 43215
Martinsville, VA
Click here to add this to my saved trials
344
mi
from 43215
Richmond, VA
Virginia Commonwealth University Massey Cancer Center
344
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
2071
mi
from 43215
Pismo Beach, CA
Clinical Research Facility
2071
mi
from 43215
Pismo Beach, CA
Click here to add this to my saved trials
270
mi
from 43215
Chicago, IL
University of Chicago Cancer Research Center
270
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
316
mi
from 43215
Normal, IL
Community Cancer Center
316
mi
from 43215
Normal, IL
Click here to add this to my saved trials
319
mi
from 43215
Ottawa, IL
Oncology Hematology Associates of Central Illinois, PC - Ottawa
319
mi
from 43215
Ottawa, IL
Click here to add this to my saved trials
352
mi
from 43215
Peoria, IL
CCOP - Illinois Oncology Research Association
352
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
349
mi
from 43215
Peoria, IL
Oncology Hematology Associates of Central Illinois, PC - Peoria
349
mi
from 43215
Peoria, IL
Click here to add this to my saved trials
170
mi
from 43215
Kokomo, IN
Howard Community Hospital
170
mi
from 43215
Kokomo, IN
Click here to add this to my saved trials
201
mi
from 43215
Mishawaka, IN
Michiana Hematology-Oncology, PC - South Bend
201
mi
from 43215
Mishawaka, IN
Click here to add this to my saved trials
205
mi
from 43215
South Bend, IN
CCOP - Northern Indiana CR Consortium
205
mi
from 43215
South Bend, IN
Click here to add this to my saved trials
230
mi
from 43215
Westville, IN
Michiana Hematology Oncology PC - La Porte
230
mi
from 43215
Westville, IN
Click here to add this to my saved trials
627
mi
from 43215
Overland Park, KA
Saint Luke's Hospital - South
627
mi
from 43215
Overland Park, KA
Click here to add this to my saved trials
622
mi
from 43215
Prairie Village, KA
CCOP - Kansas City
622
mi
from 43215
Prairie Village, KA
Click here to add this to my saved trials
343
mi
from 43215
Baltimore, MD
Greenebaum Cancer Center at University of Maryland Medical Center
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
322
mi
from 43215
Bethesda, MD
National Naval Medical Center
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
640
mi
from 43215
Boston, MA
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
640
mi
from 43215
Boston, MA
Click here to add this to my saved trials
232
mi
from 43215
Saint Joseph, MI
Lakeland Regional Cancer Care Center - St. Joseph
232
mi
from 43215
Saint Joseph, MI
Click here to add this to my saved trials
619
mi
from 43215
Kansas City, MO
Saint Luke's Cancer Institute at Saint Luke's Hospital
619
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
626
mi
from 43215
Saint Joseph, MO
Saint Joseph Oncology, Incorporated
626
mi
from 43215
Saint Joseph, MO
Click here to add this to my saved trials
397
mi
from 43215
Saint Louis, MO
Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis
397
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
1756
mi
from 43215
Las Vegas, NV
CCOP - Nevada Cancer Research Foundation
1756
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
303
mi
from 43215
Asheville, NC
Mission Hospitals - Memorial Campus
303
mi
from 43215
Asheville, NC
Click here to add this to my saved trials
419
mi
from 43215
Goldsboro, NC
Wayne Memorial Hospital, Incorporated
419
mi
from 43215
Goldsboro, NC
Click here to add this to my saved trials
2
mi
from 43215
Columbus, OH
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
590
mi
from 43215
Burlington, VT
Fletcher Allen Health Care - University Health Center Campus
590
mi
from 43215
Burlington, VT
Click here to add this to my saved trials
382
mi
from 43215
Elkton, MD
Union Hospital of Cecil County
382
mi
from 43215
Elkton, MD
Click here to add this to my saved trials
328
mi
from 43215
Washington,
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
328
mi
from 43215
Washington,
Washington Cancer Institute at Washington Hospital Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
609
mi
from 43215
Berlin, VT
Mountainview Medical
609
mi
from 43215
Berlin, VT
Click here to add this to my saved trials
Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
Nonmyeloablative Stem Cell Transplantation With or Without Lenalidomide for Chronic Lymphocytic Leukemia (RV-CLL-PI-0294)
Status: Enrolling
Updated:  12/31/1969
995
mi
from 43215
Houston, TX
Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
Nonmyeloablative Stem Cell Transplantation With or Without Lenalidomide for Chronic Lymphocytic Leukemia (RV-CLL-PI-0294)
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
A Randomized Study of Decitabine Alternating With Clofarabine Versus Decitabine Until Failure in Patients With Higher Risk Myelodysplastic Syndromes (MDS)
Status: Enrolling
Updated:  12/31/1969
995
mi
from 43215
Houston, TX
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)
A Randomized Study of Decitabine Alternating With Clofarabine Versus Decitabine Until Failure in Patients With Higher Risk Myelodysplastic Syndromes (MDS)
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
547
mi
from 43215
New Britain, CT
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
The Hospital of Central Connecticut
547
mi
from 43215
New Britain, CT
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
542
mi
from 43215
Southington, CT
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Cancer Center of Central Connecticut
542
mi
from 43215
Southington, CT
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
299
mi
from 43215
North Chicago, IL
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
North Chicago VA Medical Center
299
mi
from 43215
North Chicago, IL
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
364
mi
from 43215
Paducah, KY
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Purchase Cancer Group
364
mi
from 43215
Paducah, KY
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
1757
mi
from 43215
Las Vegas, NV
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Nevada Cancer Research Foundation
1757
mi
from 43215
Las Vegas, NV
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
476
mi
from 43215
Hackensack, NJ
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
The Cancer Center, Hackensack University Medical Center
476
mi
from 43215
Hackensack, NJ
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
444
mi
from 43215
Somerville, NJ
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Somerset Hematology Oncology Associates
444
mi
from 43215
Somerville, NJ
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
288
mi
from 43215
Buffalo, NY
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Roswell Park Cancer Center
288
mi
from 43215
Buffalo, NY
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
416
mi
from 43215
Philadelphia, PA
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Drexel University College of Medicine
416
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
390
mi
from 43215
Pottstown, PA
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Pottstown Memorial Medical Center
390
mi
from 43215
Pottstown, PA
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
374
mi
from 43215
West Reading, PA
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Berks Hematology Oncology Associates, Inc
374
mi
from 43215
West Reading, PA
Click here to add this to my saved trials
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated:  12/31/1969
523
mi
from 43215
Charleston, SC
Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)
A Phase 3, Multicenter, Randomized, Openlabel, Parallel-Group Study of the Efficacy and Safety of Lenalidomide (Revlimid®) Versus Chlorambucil as First-Line Therapy for Previously Untreated Elderly Patients With B-Cell Chronic Lymphocytic Leukemia (The Origin Trial)
Status: Enrolling
Updated: 12/31/1969
Charleston Hematology Oncology, PA
523
mi
from 43215
Charleston, SC
Click here to add this to my saved trials